Amphotericin B, the Wonder of Today’s Pharmacology Science: Persisting Usage for More Than Seven Decades
Background: Despite several available topical and systemic antifungal drugs for the treatment of fungal infections, Amphotericin B (AmB) is still one of the most common first-line choices in treating systemic fungal infection for more than seven decades after its discovery. Objectives: Amphoteric...
Main Author: | Falah Hasan Obayes al-Khikani |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2020-09-01
|
Series: | Pharmaceutical and Biomedical Research |
Subjects: | |
Online Access: | http://pbr.mazums.ac.ir/article-1-297-en.html |
Similar Items
-
REFRACTORY FUNGAL VAGINITIS TREATED BY TOPICAL AMPHOTERICIN B. Review
by: Falah Hasan Obayes AL-Khikani
Published: (2020-06-01) -
Pulmonary mycoses treated by topical amphotericin B
by: Falah Hasan Obayes AL-Khikani
Published: (2020-01-01) -
Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins
by: Carmen López-Castillo, et al.
Published: (2018-12-01) -
Amphotericin B as antiviral drug: Possible efficacy against COVID-19
by: Falah Hasan Obayes AL-Khikani
Published: (2020-01-01) -
Amphotericin B Revisited
by: Sahil Kumar, et al.
Published: (2021-01-01)